KPC is an enzyme, while CRE is a type of bacteria; specifically, KPC is an enzyme produced by some CRE bacteria, giving the bacteria resistance to carbapenem antibiotics.
Here's a more detailed breakdown:
-
CRE (Carbapenem-Resistant Enterobacteriaceae):
- CRE are a family of bacteria that are difficult to treat because they are resistant to carbapenems. Carbapenems are a class of strong antibiotics often used as a last resort for bacterial infections.
- The term "CRE" refers to the bacteria themselves.
- Examples of Enterobacteriaceae include Klebsiella and Escherichia coli (E. coli).
- CRE infections can be serious, even deadly.
-
KPC (Klebsiella pneumoniae carbapenemase):
- KPC is an enzyme (specifically a carbapenemase) that certain bacteria produce. This enzyme allows the bacteria to break down carbapenem antibiotics, rendering them ineffective.
- While KPC was first discovered in Klebsiella pneumoniae, other types of bacteria can also produce KPC.
- Bacteria that produce KPC are, by definition, CRE.
Analogy:
Think of it this way: CRE is a fortified castle (the bacteria), and KPC is the castle's secret weapon (the enzyme) that destroys the enemy's siege equipment (carbapenem antibiotics). The castle is the entity; the weapon is a mechanism that allows it to survive.
Key Differences Summarized:
| Feature | KPC | CRE |
|---|---|---|
| What it is | An enzyme (carbapenemase) | A type of bacteria (Carbapenem-Resistant Enterobacteriaceae) |
| Function | Breaks down carbapenem antibiotics, providing resistance. | Resistant to carbapenem antibiotics; may produce KPC (but not all CRE produce KPC). |
| Relationship | Produced by some CRE bacteria. | Can produce KPC, but resistance can also be due to other mechanisms. |
In summary, KPC is a specific enzyme that can contribute to carbapenem resistance, and CRE are the bacteria that exhibit carbapenem resistance, sometimes (but not always) because they produce KPC. There are other enzymes besides KPC that can cause CRE, but they are less common in the United States.
